S&P 500
(0.00%) 5 187.67 points
Dow Jones
(0.44%) 39 056 points
Nasdaq
(-0.18%) 16 303 points
Oil
(0.33%) $79.25
Gas
(-0.41%) $2.18
Gold
(-0.26%) $2 316.30
Silver
(-0.11%) $27.57
Platinum
(0.00%) $984.60
USD/EUR
(0.05%) $0.931
USD/NOK
(0.15%) $10.91
USD/GBP
(0.03%) $0.800
USD/RUB
(0.01%) $91.75

リアルタイムの更新: Thyrocare Technologies [THYROCARE.NS]

取引所: NSE セクター: Healthcare 産業: Diagnostics & Research
最終更新日時8 5月 2024 @ 19:00

-0.68% INR 616.25

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 19:00):

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others...

Stats
本日の出来高 18 561.00
平均出来高 108 096
時価総額 32.63B
EPS INR0 ( 2024-02-01 )
次の収益日 ( INR0 ) 2024-05-14
Last Dividend INR18.00 ( 2023-04-20 )
Next Dividend INR0 ( N/A )
P/E 50.43
ATR14 INR0.572 (0.09%)

ボリューム 相関

長: 0.04 (neutral)
短: 0.26 (neutral)
Signal:(57.731) Neutral

Thyrocare Technologies 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Thyrocare Technologies 相関 - 通貨/商品

The country flag 0.33
( neutral )
The country flag -0.43
( neutral )
The country flag 0.15
( neutral )
The country flag -0.60
( weak negative )
The country flag 0.60
( weak )
The country flag -0.32
( neutral )

Thyrocare Technologies 財務諸表

Annual 2022
収益: INR5.27B
総利益: INR3.63B (69.01 %)
EPS: INR12.16
FY 2022
収益: INR5.27B
総利益: INR3.63B (69.01 %)
EPS: INR12.16
FY 2022
収益: INR5.89B
総利益: INR4.19B (71.18 %)
EPS: INR33.30
FY 2021
収益: INR4.95B
総利益: INR3.31B (66.86 %)
EPS: INR21.41

Financial Reports:

No articles found.

Thyrocare Technologies Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR18.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Thyrocare Technologies Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.68 - low (50.00%) | Divividend Growth Potential Score: 5.11 - Potential for dividend initiation, but uncertain (2.23%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.50 2016-09-01
Last Dividend INR18.00 2023-04-20
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 11 --
Total Paid Out INR105.50 --
Avg. Dividend % Per Year 1.39% --
Score 2.34 --
Div. Sustainability Score 2.68
Div.Growth Potential Score 5.11
Div. Directional Score 3.90 --
Next Divdend (Est)
(2024-06-24)
INR19.97 Estimate 3.36 %
Dividend Stability
0.27 Very Poor
Dividend Score
2.34
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR10.00 1.55%
2019 INR25.00 4.64%
2020 INR10.00 1.85%
2021 INR15.00 1.60%
2022 INR15.00 1.35%
2023 INR18.00 2.94%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SUNTV.NS Dividend Knight 2023-08-22 Quarterly 19 1.94%
NAVNETEDUL.NS Dividend Junior 2023-08-07 Annually 22 1.10%
HPIL.NS Dividend Junior 2023-09-29 Annually 5 0.89%
CARERATING.NS Dividend Knight 2023-07-06 Semi-Annually 12 1.81%
ROSSELLIND.NS No Dividend Player 2023-07-20 Sporadic 12 0.12%
LFIC.NS Dividend Junior 2023-08-01 Annually 15 1.73%
GAEL.NS Dividend Junior 2023-08-25 Annually 23 0.27%
APOLLOPIPE.NS Dividend Junior 2023-09-15 Annually 3 0.07%
TCPLPACK.NS Dividend Junior 2023-07-27 Annually 7 1.08%
OFSS.NS Dividend Knight 2023-05-09 Annually 23 4.19%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1181.5007.6310.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1281.5009.6910.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM24.851.0001.9091.909[3 - 30]
operatingCashFlowPerShareTTM16.822.004.398.79[0 - 30]
freeCashFlowPerShareTTM16.822.001.5903.18[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.7081.0001.5411.541[0.2 - 0.8]
operatingProfitMarginTTM0.1681.0008.638.63[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score2.68

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM49.841.0005.070[1 - 100]
returnOnEquityTTM0.1282.509.8010.00[0.1 - 1.5]
freeCashFlowPerShareTTM16.822.004.393.18[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM16.822.004.398.79[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.8971.5007.350[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1611.0008.480[0.1 - 0.5]
Total Score5.11

Thyrocare Technologies

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。